<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01047826</url>
  </required_header>
  <id_info>
    <org_study_id>RC09/128</org_study_id>
    <nct_id>NCT01047826</nct_id>
  </id_info>
  <brief_title>M.I.P.O. vs Intramedullary Nailing in Tibia Fractures</brief_title>
  <acronym>MINT</acronym>
  <official_title>Intramedullary Nailing vs. M.I.P.O. in Fractures of the Tibia a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>King Abdullah International Medical Research Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>King Abdullah International Medical Research Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators are comparing two methods of standard treatments in distal tibial&#xD;
      fractures. locked plating (M.I.P.O. technique) with intramedullary nailing.&#xD;
&#xD;
      the investigators are hypothesizing that M.I.P.O group is superior to nailing in fractures of&#xD;
      the distal third of the tibia.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The kind of plates the investigators are comparing are the Locked plates form Synthes ® using&#xD;
      the minimally invasive technique vs the Expert Tibial Nail® from Synthes ®&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2010</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate Of Malunion</measure>
    <time_frame>6 months</time_frame>
    <description>Any healing that occurs with any one of the following:&#xD;
More than 5 degree angulation in the anterior-posterior or lateral view or Rotation of more than 10 degrees or Shorting of more than 1 cm.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The Short Form (12) Health Score (SF-12v2®)</measure>
    <time_frame>every 3 months till healing or 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Loss</measure>
    <time_frame>during the time of surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiation exposure</measure>
    <time_frame>During the time of Surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of Surgery</measure>
    <time_frame>During the time of Surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infection Rate</measure>
    <time_frame>every 3 months till healing or 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Stay</measure>
    <time_frame>After Surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time Of Fracture Healing</measure>
    <time_frame>6 months</time_frame>
    <description>Clinical Criteria: No pain or tenderness while wight bearing or palpating the fracture site&#xD;
Radiological Criteria: Bridging of the fracture site in anterior-posterior and lateral views.&#xD;
Using these two criteria we well be able to measure the time of healing in our study subjects.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Tibia Fracture</condition>
  <arm_group>
    <arm_group_label>M.I.P.O. Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>subjects who have been randomized to the M.I.P.O. group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intramedullary Nail group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects who have been Randomized to the I.M. group</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Minimally Invasive Plate Osteosynthesis</intervention_name>
    <description>Fractures well be treated with locked plates using M.I.P.O. Technique</description>
    <arm_group_label>M.I.P.O. Group</arm_group_label>
    <other_name>Minimally invasive percutaneous plate osteosynthesis (MIPPO)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>intramedullary tibial Nailing</intervention_name>
    <description>Fractures well be fixed using intramedullary nails</description>
    <arm_group_label>Intramedullary Nail group</arm_group_label>
    <other_name>Expert Tibial Nail ®</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Males and Females aged from 18-60 years&#xD;
&#xD;
          -  Closed Tibia Fracture&#xD;
&#xD;
          -  Tibia Fracture Müller AO Class 43-A&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Intra-articular Fractures&#xD;
&#xD;
          -  Open fractures&#xD;
&#xD;
          -  fracturesSubjects with documented Marfan's syndrome or Ehlers-Danlos syndrome or&#xD;
             Hajdu-Cheney syndrome.&#xD;
&#xD;
          -  Post organ transplant patients (except Cornea transplant)&#xD;
&#xD;
          -  Subjects on immunosuppressive medications&#xD;
&#xD;
          -  Subjects with diagnosed with&#xD;
&#xD;
               -  Osteogenesis imperfecta&#xD;
&#xD;
               -  Osteopetrosis&#xD;
&#xD;
               -  Paget disease of bone&#xD;
&#xD;
               -  Renal osteodystrophy&#xD;
&#xD;
          -  Subjects with diagnosed neoplasms or mitotic illnesses&#xD;
&#xD;
          -  Subjects receiving growth hormone&#xD;
&#xD;
          -  Unable to comply with postoperative rehabilitation e.g. head injury&#xD;
&#xD;
          -  Impending compartment syndrome&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Husam A AL-Rumaih, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Guard Heath Affaires, Saudi Arabia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wael S Taha, MD</last_name>
    <role>Study Director</role>
    <affiliation>National Guard Health Affairs</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sami I AL-Essia, MD</last_name>
    <role>Study Chair</role>
    <affiliation>National Guard Health Affairs</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Husam A AL-Rumaih, MD</last_name>
    <phone>+96612520088</phone>
    <phone_ext>14119</phone_ext>
    <email>rumaih@me.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Wael S Taha, MD</last_name>
    <phone>+96612520088</phone>
    <phone_ext>14117</phone_ext>
    <email>waelstaha@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>King Abdullah International Medical Research Center</name>
      <address>
        <city>Riyadh</city>
        <state>Central</state>
        <zip>11426</zip>
        <country>Saudi Arabia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Husam A AL-Rumaih, MD</last_name>
      <phone>+96612520088</phone>
      <phone_ext>14119</phone_ext>
      <email>rumaih@me.com</email>
    </contact>
    <contact_backup>
      <last_name>Sami I AL-Essia, MD</last_name>
      <phone>+96612520088</phone>
      <phone_ext>14119</phone_ext>
      <email>saleissa@yahoo.com</email>
    </contact_backup>
    <investigator>
      <last_name>Wael S Taha, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Abdulaziz AL-Ammari, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Saudi Arabia</country>
  </location_countries>
  <link>
    <url>http://www.kaimrc.med.sa/</url>
    <description>King Abdullah International Medical Research Center</description>
  </link>
  <link>
    <url>http://www.minttrial.com</url>
    <description>The Trials webpage</description>
  </link>
  <verification_date>October 2010</verification_date>
  <study_first_submitted>January 12, 2010</study_first_submitted>
  <study_first_submitted_qc>January 12, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 13, 2010</study_first_posted>
  <last_update_submitted>June 22, 2011</last_update_submitted>
  <last_update_submitted_qc>June 22, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 23, 2011</last_update_posted>
  <responsible_party>
    <name_title>Husam A. AL-Rumaih/Dr</name_title>
    <organization>King Abdullah International Medical Research Center</organization>
  </responsible_party>
  <keyword>Fractured Tibia</keyword>
  <keyword>Expert Tibial Nail</keyword>
  <keyword>Minimally Invasive Plate Osteosynthesis (M.I.P.O)</keyword>
  <keyword>Intramedullary Nailing</keyword>
  <keyword>Locked Plate</keyword>
  <keyword>distal third</keyword>
  <keyword>43-A</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Tibial Fractures</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

